Cannabimimetic Treatment of Obstructive Sleep Apnea: A Proof of Concept Trial
Phase of Trial: Phase II
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Dronabinol (Primary)
- Indications Sleep apnoea syndrome
- Focus Proof of concept; Registrational; Therapeutic Use
- Acronyms PACE
- 08 Sep 2017 According to a RespireRx Pharmaceuticals media release, results from this trial will be presented at the 2017 Rodman & Renshaw Conference.
- 25 Aug 2017 According to a RespireRx Pharmaceuticals media release, on june 6, 2017 results from this trial were presented at the Sleep 2017 conference.
- 14 Jun 2017 According to a RespireRx Pharmaceuticals media release, this study was fully funded by the National Heart, Lung and Blood Institute of the National Institutes of Health.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History